TL;DR | The Highlights
- Life sciences organizations depend on complex networks of operational, regulatory, and commercial systems. But having those systems connected doesn’t necessarily mean the business is working from the same information.
- Integration gaps show up beyond IT, affecting customer experiences, supply chain responsiveness, commercial planning, and the ability to make informed decisions.
- AI agents raise the stakes. Integration must now support not only the movement of data, but the context, governance, and permissions required to act on it.
- Technology alone won’t resolve fragmented processes or unclear data ownership. Those decisions need to be addressed through integration architecture and business accountability.
- The goal isn’t to connect everything. It’s to make the right information available, reliable, and actionable where the business needs it.
A life sciences organization can have an impressively connected technology environment and still struggle to answer a relatively straightforward customer question. Where is my order? Is this product available? Why hasn’t a shipment arrived? What’s the status of a return?
The answers may already exist somewhere in the business. The ERP holds the order. A third-party logistics provider (3PL) has the shipment details. Manufacturing knows the inventory position. Salesforce holds the customer relationship and service history.
Each system may be doing exactly what it was designed to do. Yet getting a complete, reliable answer can still require several people, multiple applications, and a few emails back and forth. That’s the distinction worth paying attention to.
Having connected systems doesn’t necessarily mean having a connected business.
For life sciences organizations, where operational complexity, regulatory requirements, and commercial expectations intersect, that difference has significant consequences. And as AI becomes more involved in how businesses access information and execute work, the limitations of traditional integration approaches are becoming harder to overlook.
Integration Has to Work Beyond Individual Systems
Life sciences businesses have always depended on a complex technology landscape. ERP, laboratory, manufacturing, quality, commercial, and supply chain systems all serve different purposes, often with different owners and requirements.
Middleware and integration platforms such as MuleSoft and Boomi help these applications exchange information securely and reliably. But technical connectivity is only one part of the equation.
An organization might have sophisticated integrations supporting manufacturing and quality processes while commercial teams still rely on delayed distributor feeds or manual reconciliation. Another might have invested heavily in Salesforce without fully connecting it to the operational systems that determine what can actually be promised or delivered.
Neither situation necessarily points to a technology failure. Integration decisions are often made around individual systems, while the business outcomes they need to support extend well beyond them.
The real measure of integration maturity isn’t how many applications can exchange data. It’s whether that information is accurate, timely, and accessible when someone needs to make a decision.
The Business Feels the Gaps, Not the Technology
Consider a customer contacting a medical device manufacturer about a delayed shipment.
The service team can see the customer history in Salesforce. The ERP holds the order status. A logistics provider has the latest shipping information. But if those details aren’t accessible together, the customer still doesn’t get a reliable answer.
That same disconnect can affect commercial forecasting, distributor relationships, inventory planning, and supply chain responsiveness.
And in life sciences, some of these workflows carry additional responsibilities. Product complaints may need to enter regulated quality processes, while returns and chargebacks require appropriate reconciliation and controls.
Connecting those processes isn’t simply about making information move faster. It’s about ensuring the right information reaches the right place, with the context and traceability the process requires.
The point is that integration success should be measured by what the business can confidently do with the information, not just whether the data arrived.
In Life Sciences, Connected Data Also Has to Be Defensible
There’s another layer to this conversation that makes life sciences different from many other industries. Not every data exchange carries the same risk, and not every workflow requires the same controls.
An integration supporting inventory availability serves a different purpose from one handling product complaints, quality records, or potentially reportable adverse events. For example, a customer service interaction may reveal a product quality concern. That information needs to reach the appropriate quality or regulatory intake process, with sufficient context and traceability to support the organization’s applicable obligations.
A distributor return or wholesaler chargeback presents a different challenge. Those transactions may require reconciliation against shipment, sales, contract, and financial records to support accurate processing and auditability.
Both scenarios depend on connected information, but the controls and responsibilities are not interchangeable.
This is where a purely technical approach to integration can fall short. Moving data successfully doesn’t establish whether the right process was triggered, whether the receiving system has sufficient context, or whether the appropriate team is accountable for what happens next. Those decisions need to be made before the integration is built.
And as organizations connect more systems, partners, and customer-facing workflows, the importance of understanding those dependencies only grows. The goal isn’t to apply the same level of control to every integration. It’s to design each connection around the business process, the risks involved, and the decisions that depend on it.
AI Is Changing the Expectations of Integration
Historically, enterprise integration has focused on exchanging information between systems and automating repetitive processes. Those requirements still matter. But AI is introducing a different expectation.
An AI agent answering a distributor’s question about a delayed shipment may need to access order details, inventory availability, shipment status, and relevant account information before responding or initiating a follow-up.
- What happens when those systems disagree?
- Which information should the agent trust?
- And what actions should it be allowed to take?
These aren’t questions an AI model should resolve independently. They’re questions about architecture, business rules, and governance.
On Salesforce, MuleSoft can support integration and workflow orchestration, Data 360 can help unify and activate relevant business context, and Agentforce can use that context to support approved actions. But these capabilities don’t automatically determine which system owns the order, how conflicting information should be handled, or when an issue requires human intervention.
AI doesn’t eliminate the need for integration discipline. It makes the consequences of getting it wrong more immediate and potentially more scalable.
The Hardest Integration Decisions Aren’t Always Technical
When integration challenges arise, the instinct is often to start with the technology. Do we need a new API? Should this process be real-time? Is it time to replace our middleware?
Those are valid questions, but they shouldn’t come first.
Before deciding how systems communicate, organizations need to establish which information matters, where it originates, who owns it, and what happens when something changes.
The ERP may own order processing. Salesforce may manage the customer relationship. A logistics provider may have the most current shipment status. Each plays a different role, and the architecture needs to reflect those responsibilities.
That accountability also needs to continue after implementation. Systems change, partners update their processes, and business requirements evolve. Without monitoring, ownership, and change management, even well-designed integrations can become unreliable.
Sometimes, an integration problem is really an unresolved business decision showing up as a technical limitation. Recognizing that distinction is often more valuable than immediately introducing another tool.
Connect for the Outcome, Not Just the Architecture
The next step for life sciences organizations isn’t necessarily another integration project. It’s identifying where disconnected information is preventing the business from operating effectively.
Start with a decision or workflow that consistently creates friction. Determine which systems hold the necessary information, how current it needs to be, who owns it, and what controls are required. Sometimes the answer will be a new integration. Other times, it may mean improving an existing connection, addressing inconsistent data, or clarifying process ownership.
At Lane Four, we approach integration through that broader business lens, connecting Salesforce and the surrounding enterprise systems to the commercial processes and outcomes they need to support. Because connecting systems is only part of the work. Making those connections meaningful to the business is where the real value begins.
If your systems are connected but your teams are still working around the gaps, let’s chat.
Let's chat!
